Kim M J, Ciletti N, Michel S, Reichert U, Rosenfield R L
Departments of Pediatrics and Medicine, Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, USA.
J Invest Dermatol. 2000 Feb;114(2):349-53. doi: 10.1046/j.1523-1747.2000.00868.x.
Retinoic acid derivatives (retinoids) exert their pleiotropic effects on cell development through specific nuclear receptors, the retinoic acid receptors and retinoid X receptors. Despite recent progress in understanding the cellular and molecular mechanisms of retinoid activity, it is unknown which of the retinoid receptor pathways are involved in the specific processes of sebocyte growth and development. In this study, we investigated the roles of specific retinoid receptors in sebocyte growth and differentiation, by testing the effects of selective retinoic acid receptor and retinoid X receptor ligands at concentrations between 10-10 M and 10-6 M in a primary rat preputial cell monolayer culture system. Cell growth was determined by number of cells and colonies, and cell differentiation by analysis of lipid-forming colonies. All-trans retinoic acid and selective retinoic acid receptor agonists (CD271 = adapalene, an RAR-beta,gamma agonist; CD2043 = retinoic acid receptor pan-agonist; and CD336 = Am580, an RAR-alpha agonist) caused significant decreases in numbers of cells, colonies, and lipid-forming colonies, but with an exception at high doses of all-trans retinoic acid (10-6 M), with which only a small number of colonies grew but they became twice as differentiated as controls (42.2 +/- 4.0% vs 22.6 +/- 2.7%, mean +/- SEM, lipid-forming colonies, p < 0.01). Furthermore, the RAR-beta,gamma antagonist CD2665 antagonized the suppressive effects of all-trans retinoic acid, adapalene, and CD2043 on both cell growth and differentiation. In contrast, the retinoid X receptor agonist CD2809 increased cell growth slightly and lipid-forming colonies dramatically in a clear dose-related manner to a maximum of 73.7% +/- 6.7% at 10-6 M (p < 0. 001). Our data suggest that retinoic acid receptors and retinoid X receptors differ in their roles in sebocyte growth and differentiation: (i) retinoic acid receptors, especially the beta and/or gamma subtypes, mediate both the antiproliferative and antidifferentiative effects of retinoids; (ii) retinoid X receptors mediate prominent differentiative and weak proliferative effects; (iii) the antiproliferative and antidifferentiative effects of all-trans retinoic acid are probably mediated by retinoic acid receptors, whereas its differentiative effect at high dose may be mediated by retinoid X receptors via all-trans retinoic acid metabolism to 9-cis retinoic acid, the natural ligand of retinoid X receptors.
维甲酸衍生物(类视黄醇)通过特定的核受体,即维甲酸受体和类视黄醇X受体,对细胞发育发挥多效性作用。尽管在理解类视黄醇活性的细胞和分子机制方面取得了进展,但尚不清楚类视黄醇受体途径中的哪一条参与了皮脂腺细胞生长和发育的特定过程。在本研究中,我们通过在原代大鼠包皮细胞单层培养系统中测试浓度介于10⁻¹⁰ M和10⁻⁶ M之间的选择性维甲酸受体和类视黄醇X受体配体的作用,研究了特定类视黄醇受体在皮脂腺细胞生长和分化中的作用。通过细胞数量和集落数量来确定细胞生长情况,通过分析形成脂质的集落来确定细胞分化情况。全反式维甲酸和选择性维甲酸受体激动剂(CD271 = 阿达帕林,一种RAR-β、γ激动剂;CD2043 = 维甲酸受体泛激动剂;CD336 = Am580,一种RAR-α激动剂)导致细胞、集落和形成脂质的集落数量显著减少,但高剂量全反式维甲酸(10⁻⁶ M)除外,在该剂量下只有少量集落生长,但它们的分化程度是对照组的两倍(42.2±4.0%对22.6±2.7%,平均值±标准误,形成脂质的集落,p<0.01)。此外,RAR-β、γ拮抗剂CD2665拮抗了全反式维甲酸、阿达帕林和CD2043对细胞生长和分化的抑制作用。相反,类视黄醇X受体激动剂CD2809以明显的剂量相关方式轻微增加细胞生长,并显著增加形成脂质的集落,在10⁻⁶ M时达到最大值73.7%±6.7%(p<0.001)。我们的数据表明,维甲酸受体和类视黄醇X受体在皮脂腺细胞生长和分化中的作用不同:(i)维甲酸受体,尤其是β和/或γ亚型,介导类视黄醇的抗增殖和抗分化作用;(ii)类视黄醇X受体介导显著的分化作用和微弱的增殖作用;(iii)全反式维甲酸的抗增殖和抗分化作用可能由维甲酸受体介导,而其高剂量下的分化作用可能由类视黄醇X受体通过全反式维甲酸代谢为9-顺式维甲酸(类视黄醇X受体的天然配体)来介导。